Table 3.

Scientometric profile of the most productive and impactful organizations in stem cell therapy for type 1 diabetes during 1999–2020

S.no	Organization	TP	TC	CPP	HI	ICP	ICP (%)	RCI
Most productive organizations
1	Harvard Medical School, USA	84	4964	59.1	28	45	53.6	1.8
2	IRCCS San Raffaele Scientific Institute, Italy	45	2401	53.4	32	7	8.3	1.6
3	University of Florida, USA	43	1995	46.4	15	4	4.8	1.4
4	INSERM, France	34	1073	31.6	20	3	3.6	0.9
5	University of Sao Paulo, Brazil	31	1346	43.4	14	3	3.6	1.3
6	Massachusetts General Hospital, USA	30	2316	77.2	15	4	4.8	2.3
7	Brigham & Women’s Hospital, USA	28	2568	91.7	14	5	6.0	2.7
8	Children’s Hospital, Boston, USA	28	2620	93.6	22	6	7.1	2.8
9	University of California, San Francisco, USA	27	2765	102.4	7	3	3.6	3.0
10	University of Alberta, Canada	26	1775	68.3	5	3	3.6	2.0
Most impactful organizations
1	University of California, San Fransico, USA	27	2765	102.4	7	3	3.6	3.0
2	Stanford University School of Medicine, USA	19	1941	102.2	12	6	7.1	3.0
3	Children’s Hospital, Boston, USA	28	2620	93.6	22	6	7.1	2.8
4	Brigham & Women’s Hospital, USA	28	2568	91.7	14	5	6.0	2.7
5	Massachsetts General Hospital, USA	30	2316	77.2	15	4	4.8	2.3
6	Harvard University, USA	25	1884	75.4	5	6	7.1	2.2
7	University of Alberta, Canada	26	1775	68.3	5	3	3.6	2.0
8	University of Pittsburg, School of Medicine, USA	23	1548	67.3	8	5	6.0	2.0
9	Harvard Medical School, USA	84	4964	59.1	28	45	53.6	1.8
10	Harvard Stem Cell Institute, USA	22	1307	59.4	8	4	4.8	1.8

Abbreviations: TP, total publications; TC, total citations; CPP, citations per publication; HI, Hirsch Index; ICP, international collaborative publications; RCI, relative citation index